Joshua J. Field, MD, MS

Professor

view physician profile

Locations

Froedtert Hospital
Children's Wisconsin - Milwaukee
Children's Wisconsin Clinics - Milwaukee
Cancer Center - Moorland Reserve Health Center

Specialties

Hematology

Languages

English

Education

MD - Doctor of Medicine
MS

Biography

Dr. Joshua Field is an Associate Professor of Medicine in the Division of Hematology and Oncology at the Medical College of Wisconsin. He is also serving as Section Chief of Benign Hematology and Medical Director of the Sickle Cell Clinic in the Froedtert Hospital. Dr. Field specializes in the treatment of sickle cell disease and other benign hematological disorders at Froedtert Hospital Dr. Field graduated medical school from the University of Iowa. He completed an internal medicine residency and fellowships in hematology and transfusion medicine at Washington University in St. Louis, where he was chief resident in internal medicine and chief fellow in hematology and oncology.

Dr. Field is also serving as Senior Medical Director and Senior Investigator in Versiti.

Research Interests

Dr. Field is board certified in transfusion medicine and hematology. He conducts clinical and translational research studies in adults with sickle cell disease.

Preliminary construct validity of patient-reported outcomes to assess chronic pain in adults with sickle cell disease.

(Mucalo L, Field JJ, Highland J, Khan H, Hankins JS, Singh A, Brandow AM.) Blood Adv. 2023 Jul 25;7(14):3658-3665 PMID: 37058480 PMCID: PMC10365933 SCOPUS ID: 2-s2.0-85183192690 04/15/2023
Evaluating the Discriminatory Ability of the Sickle Cell Data Collection Program's Administrative Claims Case Definition in Identifying Adults With Sickle Cell Disease: Validation Study.

(Singh A, Sontag MK, Zhou M, Dasgupta M, Crume T, McLemore M, Galadanci N, Randall E, Steiner N, Brandow AM, Koch K, Field JJ, Hassell K, Snyder AB, Kanter J.) JMIR Public Health Surveill. 2023 Jun 28;9:e42816 PMID: 37379070 PMCID: PMC10365593 SCOPUS ID: 2-s2.0-85163580848 06/28/2023
Secondary Neoplasms After Hematopoietic Cell Transplant for Sickle Cell Disease.

(Eapen M, Brazauskas R, Williams DA, Walters MC, St Martin A, Jacobs BL, Antin JH, Bona K, Chaudhury S, Coleman-Cowger VH, DiFronzo NL, Esrick EB, Field JJ, Fitzhugh CD, Kanter J, Kapoor N, Kohn DB, Krishnamurti L, London WB, Pulsipher MA, Talib S, Thompson AA, Waller EK, Wun T, Horowitz MM.) J Clin Oncol. 2023 Apr 20;41(12):2227-2237 PMID: 36623245 PMCID: PMC10448940 SCOPUS ID: 2-s2.0-85152619905 01/10/2023
Hypoxic storage of donor red cells preserves deformability after exposure to plasma from adults with sickle cell disease.

(Karafin MS, Field JJ, Ilich A, Li L, Qaquish BF, Shevkoplyas SS, Yoshida T.) Transfusion. 2023 Jan;63(1):193-202 PMID: 36310401 SCOPUS ID: 2-s2.0-85141155772 11/01/2022
Fostamatinib for the treatment of warm antibody autoimmune hemolytic anemia: Phase 2, multicenter, open-label study.

(Kuter DJ, Rogers KA, Boxer MA, Choi M, Agajanian R, Arnold DM, Broome CM, Field JJ, Murakhovskaya I, Numerof R, Tong S.) Am J Hematol. 2022 Jun 01;97(6):691-699 PMID: 35179251 PMCID: PMC9313871 SCOPUS ID: 2-s2.0-85125529424 02/19/2022
Gaps in the diagnosis and management of iron overload in sickle cell disease: a 'real-world' report from the GRNDaD registry.

(Wilson SR, Sears M, Williams E, Drapekin J, Sivakumar I, Padrino S, Desai PC, Hager W, Manwani D, Clay LJ, Field JJ, Kanter J, Cohen AJ, Saif Ur Rehman S, Lanzkron S, Little JA, GRNDaD investigators.) Br J Haematol. 2021 Dec;195(5):e157-e160 PMID: 34423416 SCOPUS ID: 2-s2.0-85113314912 08/24/2021
Treatment of Acute Pain in Adults With Sickle Cell Disease in an Infusion Center Versus the Emergency Department : A Multicenter Prospective Cohort Study.

(Lanzkron S, Little J, Wang H, Field JJ, Shows JR, Haywood C Jr, Saheed M, Proudford M, Robertson D, Kincaid A, Burgess L, Green C, Seufert R, Brooks J, Piehet A, Griffin B, Arnold N, Frymark S, Wallace M, Abu Al Hamayel N, Huang CY, Segal JB, Varadhan R.) Ann Intern Med. 2021 Sep;174(9):1207-1213 PMID: 34224261 SCOPUS ID: 2-s2.0-85117425920 07/06/2021
Chronic Pain Does Not Impact Baseline Circulating Cytokine Levels in Adults with Sickle Cell Disease.

(Karafin MS, Simpson P, Field JJ.) Acta Haematol. 2021;144(1):111-116 PMID: 32403100 SCOPUS ID: 2-s2.0-85085034465 05/14/2020
Social and Psychological Factors Associated With Health Care Transition for Young Adults Living With Sickle Cell Disease.

(Clayton-Jones D, Matthie N, Treadwell M, Field JJ, Mager A, Sawdy R, George Dalmida S, Leonard C, Koch KL, Haglund K.) J Transcult Nurs. 2021 Jan;32(1):21-29 PMID: 31889479 SCOPUS ID: 2-s2.0-85077517948 01/01/2020
Circulating fibrocytes as prognostic biomarkers of autoimmune interstitial lung disease.

(Odackal J, Yu V, Gomez-Manjerres D, Field JJ, Burdick MD, Mehrad B.) ERJ Open Res. 2020 Oct;6(4) PMID: 33263049 PMCID: PMC7682700 12/03/2020
Phase 2 trial of montelukast for prevention of pain in sickle cell disease.

(Field JJ, Kassim A, Brandow A, Embury SH, Matsui N, Wilkerson K, Bryant V, Zhang L, Simpson P, DeBaun MR.) Blood Adv. 2020 Mar 24;4(6):1159-1165 PMID: 32208487 PMCID: PMC7094028 SCOPUS ID: 2-s2.0-85082514389 03/26/2020
American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support.

(Chou ST, Alsawas M, Fasano RM, Field JJ, Hendrickson JE, Howard J, Kameka M, Kwiatkowski JL, Pirenne F, Shi PA, Stowell SR, Thein SL, Westhoff CM, Wong TE, Akl EA.) Blood Adv. 2020 Jan 28;4(2):327-355 PMID: 31985807 PMCID: PMC6988392 SCOPUS ID: 2-s2.0-85083898038 01/28/2020

Joshua J. Field, MD, MS

Professor

Locations

Specialties

Languages

Established Patient Appointments

Moorland Reserve Health Center

New Patient Appointments

Sickle Cell Clinic

Education

Biography

Research Interests

Publications